On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
TuesdayJul 31, 2012 5:09 pm

SmallCapVoice: Marley Coffee (JAMN) Continues to Expand in California with New Distribution at Gelson’s

Marley Coffee, a sustainably grown, ethically farmed and artisan roasted gourmet coffee, today announced new distribution with Gelson’s Markets, one of the nation’s premier supermarket chains, with 17 locations in California. Just recently, all Gelson’s markets will offer Marley Coffee Organic Ground 8oz. bags in the following varieties: Get Up Stand Up (light roast), One Love 100% Ethiopian Tirgacheffe (medium roast), Mystic Morning (medium roast), and Buffalo Soldier (dark roast). “We are excited to team up with Gelson’s Markets as they share our love for providing the highest quality products to customers,” said Rohan Marley, chairman, Marley Coffee. “We are…

Continue Reading

TuesdayJul 31, 2012 2:37 pm

22nd Century Group, Inc. (XXII) Delivers 2.7Mln SPECTRUM Research Cigarettes under 5-Year Government Contract

22nd Century Group, a plant biotech company with proprietary technology for tobacco harm reduction and smoking cessation products, today announced it has delivered an additional 2.7 million SPECTRUM® research cigarettes. The SPECTRUM line is comprised of a series of cigarette styles with a fixed amount of tar, but with varying nicotine yields. The product line features 24 styles, 11 regular and 13 menthol versions, with eight levels of nicotine content. The most prevalent style of SPECTRUM has approximately 97 percent less nicotine than "light" cigarettes on the market. 22nd Century developed SPECTRUM for NIDA, a department of the National Institutes…

Continue Reading

TuesdayJul 31, 2012 1:03 pm

STWA, Inc. (ZERO) Advancing Towards Commercialization of Applied Oil Technology in China

STWA has put together an impressive package of intellectual property (developed with and exclusively licensed from Temple University), with their DOE test-proven oil pipeline flow rate enhancing Applied Oil Technology™ (AOT, essentially reduces viscosity in the pipe) and a diesel engine efficiency technology based on the same viscosity-reducing idea, ELEKTRA™, leading the pack. And that same AOT 1.2v unit which previously underwent testing with the DOE at the Rocky Mountain Oilfield Testing Center (RMOTC), handing in successful results since October of last year, was reported as being boxed up and shipped out today to Langfang, China, for the second stage…

Continue Reading

TuesdayJul 31, 2012 9:44 am

International Stem Cell Corp. (ISCO) Milestone Advancement of Transplantable Human Cornea Program Captivates Market/Doctors

International Stem Cell Corp. has made bold progress developing ethically valid human parthenogenetic stem cell (hpSC) technology that allows for pluripotent stem cell creation from unfertilized eggs, and while this technology has incredibly broad application potential, it is the recent announcement by ISCO's R&D team regarding advancement of the company's transplantable human cornea program which currently captures the attention of both investors and ophthalmologists. The June 28 release by ISCO, detailing development by the company's R&D team of a new method for deriving corneal endothelium-like cells, largely validated prior data sets gathered from collaborator Sankara Nethralaya Eye Hospital in India,…

Continue Reading

TuesdayJul 31, 2012 8:20 am

SmallCapVoice: Allezoe Medical’s (ALZM) Growing Line Up of Cutting-Edge Medical Devices

Allezoe Medical Holdings is a holding company focused on acquiring the most high-quality and in demand medical products, solutions and services that address health issues facing large populations. They are most interested in leading-edge technologies that apply proven science to offer improved outcomes and ease of use for patients, their families, and the healthcare teams that care for them. Allezoe Medical Holdings’ subsidiary, SureScreen Medical, Inc., has signed an exclusive license to develop and market a breakthrough medical technology that will, potentially, revolutionize the diagnosis and treatment of Human Papillomavirus (HPV), Bovine Papillomavirus (BPV), and potentially cervical cancer. HPV is…

Continue Reading

TuesdayJul 31, 2012 8:16 am

Limelight Networks, Inc. (LLNW) Dion Messer Receives “George Hutchinson Award” from the Federal Circuit Bar Association for Outstanding Leadership

Limelight Networks, a prominent player in Digital Presence Management, announced yesterday that its Senior Intellectual Property Corporate Counsel, Dion Messer, has received the “George Hutchinson Award” from the Federal Circuit Bar Association (FCBA). FCBA’s most prestigious award recognizes Messer and Lawrence Kass, her co-chair of the FCBA’s Veterans Appeals Committee, a partner in the New York office of Milbank, Tweed, Hadley & McCloy, for their impressive leadership and notable achievements over the years. The Veterans Appeals Committee established and manages the FCBA’s Veterans Pro Bono Program. The program centers around identifying and screening appeals filed pro se with the US…

Continue Reading

MondayJul 30, 2012 5:04 pm

SmallCapVoice: Imogo (IMTC) Forms Strategic Alliance with Contact Monkey

Imogo Mobile Technologies, a leader in secure mobile cloud services, today announced that it has formed a strategic alliance with Toronto-based Contact Monkey (www.contactmonkey.com), a rapidly growing developer and marketer of a seamless, secure and easy-to-use cloud solution that lets users better control and share their contact information. Imogo has worked out a mutually beneficial agreement with Contact Monkey that will accelerate synergistic growth in both the cloud and app markets. Under the terms of the alliance agreement, Imogo will integrate the Contact Monkey solution into the Imogo cloud offering and the two companies will cross promote each company’s product…

Continue Reading

MondayJul 30, 2012 4:58 pm

Advanced Cell Technology, Inc. (ACTC) Treats Final Patient in First Cohort of Phase ½ Trial for Stargardt’s Macular Dystrophy

Advanced Cell Technology, a biotech company focused on the field of regenerative medicine, today announced it has treated the final patient in the first patient group participating in its phase 1/2 clinical trial for Stargardt's macular dystrophy (SMD), which causes progressive vision loss and eventual blindness. The trial uses retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) as treatment for SMD. The outpatient transplant surgery was performed July 27 at Moorfields Eye Hospital in London without any complications. This is the tenth patient overall to now be treated with Advanced Cell’s RPE cell therapy. The phase…

Continue Reading

MondayJul 30, 2012 3:01 pm

Facts and Advantages Behind Duma Energy Corp. (DUMA)

Duma Energy is a growing energy company, based in Houston, Texas, with oil and gas interests in Texas, Louisiana, and Illinois. The story of the company’s past and future growth potential is perhaps best seen in the numbers and strategic advantages the company possesses. • The company produced 38,000 barrels of oil equivalent (boe) in fiscal 2011, and has already produced over 45,000 boe in the first half of fiscal 2012. • Duma lists $77 million in proven resources (with less than $12 million as booked reserves). • Most recent year-over-year revenue growth exceeds 500%. • 75% of the invested…

Continue Reading

MondayJul 30, 2012 12:04 pm

CytoSorbents Corp. (CTSO) and Its Breakthrough Medical Technology

CytoSorbents is a New Jersey based healthcare company that has developed a therapeutic device for blood purification, applicable to kidney disease, sepsis, and other life threatening diseases. CytoSorb™, the company's flagship product, uses what is called hemoperfusion technology, involving the passing of blood over adsorbent substances outside of the body to remove toxins. The specially designed adsorbent material in this case consists of biocompatible, highly porous polymer beads, each containing millions of pores and channels that can be modified to remove substances as small as drugs and as large as antibodies. The system is designed to remove excessive cytokines in…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.


Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered